Comparison of Clinical Sensitivity and Specificity for High-Risk HPV Detection by the Hybrid Capture II Assay and the Amplicor HPV Test

被引：0
|
作者：
Golnar, R. [1 ]
Bandarchi, B. [1 ]
Siadat, F. [1 ]
Hafezi, S. [1 ]
Seth, A. [1 ,2 ]
机构：
[1] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada
[2] Sunnybrook Res Inst, Toronto, ON, Canada
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2008年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：589 / 589
页数：1
相关论文
共 50 条
  • [31] High-risk HPV detection and concurrent HPV 16 and 18 typing with Abbott RealTime High Risk HPV test
    Tang, Ning
    Huang, Shihai
    Erickson, Brian
    Mak, Wai-Bing
    Salituro, John
    Robinson, John
    Abravaya, Klara
    JOURNAL OF CLINICAL VIROLOGY, 2009, 45 : S25 - S28
  • [32] COMPARISON OF COBAS® 4800 HPV ASSAY TO DIGENE HYBRID CAPTURE 2, ROCHE LINEAR ARRAY, AND AMPLICOR IN THE DETECTION OF HIGH-RISK HUMAN PAPILLOMAVIRUS GENOTYPES IN WOMEN WITH PREVIOUS ABNORMAL PAP SMEARS
    Tabrizi, S. N.
    Phillips, S.
    Garland, S. M.
    SEXUALLY TRANSMITTED INFECTIONS, 2013, 89 : A357 - A357
  • [33] Clinical Performance of the APTIMA HPV Assay for the Detection of High-Risk HPV in Head and Neck Squamous Cell Carcinomas
    Faber, E.
    Barry, J.
    Manne, J.
    Barnett, J.
    Sizemore, J.
    Smith, A.
    Talwalkar, S. S.
    Talwalkar, S. S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 1013 - 1013
  • [34] Sensitivity of the High-Risk HPV Hybrid Capture II (hrHPV HC2) Test Using SurePath Specimens in Detection of Cervical High Grade Precancerous and Cancerous Lesions
    Zhou, F.
    Pulmthanathu, R.
    Elgert, P.
    Simsir, A.
    LABORATORY INVESTIGATION, 2014, 94 : 128A - 128A
  • [35] Sensitivity of the High-Risk HPV Hybrid Capture II (hrHPV HC2) Test Using SurePath Specimens in Detection of Cervical High Grade Precancerous and Cancerous Lesions
    Zhou, F.
    Pulinthanathu, R.
    Elgert, P.
    Simsir, A.
    MODERN PATHOLOGY, 2014, 27 : 128A - 128A
  • [36] Comparison of the Cepheid Xpert HPV test and the HC2 High-Risk HPV DNA Test for detection of high-risk HPV infection in cervical smear samples in SurePath preservative fluid
    Rabaan, Ali A.
    Alfaraj, Shatha A.
    Alkhalifah, Mohammed A.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 67 (05) : 676 - 680
  • [37] Comparison of the digene hybrid capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal pap smear results
    Stevens, Matthew P.
    Garland, Suzanne M.
    Rudland, Elice
    Tan, Jeffrey
    Quinn, Michael A.
    Tabrizi, Sepehr N.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (07) : 2130 - 2137
  • [38] Comparison of a novel HPV test with the Hybrid Capture II (hcII) and a reference PCR method shows high specificity and positive predictive value for 13 high-risk human papillomavirus infections
    Baleriola, Cristina
    Millar, Douglas
    Melki, John
    Coulston, Neralie
    Altman, Phillip
    Rismanto, Nikolas
    Rawlinson, William
    JOURNAL OF CLINICAL VIROLOGY, 2008, 42 (01) : 22 - 26
  • [39] High risk HPV detection: A split sample comparison of hybrid capture and in situ hybridization
    Schiller, CL
    Hy, JM
    Escobar, MT
    Kaul, KL
    Watkin, WG
    Sturgis, CD
    LABORATORY INVESTIGATION, 2003, 83 (01) : 80A - 80A
  • [40] High risk HPV detection: A split sample comparison of hybrid capture and in situ hybridization
    Schiller, CL
    Hy, JM
    Escobar, MT
    Kaul, KL
    Watkin, WG
    Sturgis, CD
    MODERN PATHOLOGY, 2003, 16 (01) : 80A - 80A
12345